MRI-Guided Cryoablation for Focal Native Prostate Cancer

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT04797039
Status
Recruiting
Apply to this trial

Conditions

  • Primary Malignant Neoplasm of Prostate (Diagnosis)

Eligibility Criteria

Sex
MALE
Age
30 Years - 100 Years
Healthy Volunteers
Not accepted

Interventions

  • MR guided cryoablation — PROCEDURE
    MR guided cryoablation of focal biopsy proven prostate cancer

Study Details

The purpose of this research is to collect data about the MRI cryoablation procedure your doctor(s) would normally perform in order to treat the participants focal prostate cancer and to evaluate the participants condition after the participants treatment is performed. Participants have been asked to take part in this research because the participants have been diagnosed with prostate cancer and scheduled to have an ablation procedure.

Key Dates

Start date
Dec 1, 2020
Status verified
May 2026
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: MR guided cryoablation
    Focal MR guided cryoablation for low- to intermediate-grade prostate cancer

Primary Outcome Measure

Technical success of the MR-guided cryoablation [ Time Frame: Will assess for 5 years with interval assessment each year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55905
Desirae Howe-Clayton
[email protected]
507-255-0111
David Woodrum, M.D, Ph.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By research site
Mayo Clinic· Rochester, MN